reta phase 2 was -24.2% at 48 weeks and people quote it like it is a maintenance number
Right, the triple agonist question again, but with numbers this time. I have 24 data points over 24 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am…
nobody should be giving this to anyone without extensive monitoring
retatrutide is not approved anywhere for human use, posts must not read as instructions
I am going to push back on this slightly.
the dosing is steep, the early fullness reports are real, and nobody knows the human safety yet
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.